Canadian Initiative to Measure, Predict and Assess Cancer Treatment Outcomes in Patients Treated With Immuno-Oncotherapeutics
Not yet recruitingOBSERVATIONAL
Enrollment
120
Participants
Timeline
Start Date
October 31, 2025
Primary Completion Date
December 31, 2027
Study Completion Date
December 31, 2027
Conditions
Carcinoma
All Listed Sponsors
lead
Canadian Cancer Trials Group
NETWORK
NCT06630273 - Canadian Initiative to Measure, Predict and Assess Cancer Treatment Outcomes in Patients Treated With Immuno-Oncotherapeutics | Biotech Hunter | Biotech Hunter